Applied DNA Sciences, Inc.
APDN
$4.83
$0.3156.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.79% | 34.27% | 4.28% | -72.66% | -78.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.79% | 34.27% | 4.28% | -72.66% | -78.91% |
| Cost of Revenue | -3.39% | -22.36% | -18.91% | -66.49% | -75.62% |
| Gross Profit | 25.40% | 196.02% | 210.00% | -80.68% | -83.64% |
| SG&A Expenses | -0.56% | -14.63% | -18.92% | -18.63% | -14.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.25% | -11.10% | -17.50% | -28.26% | -36.06% |
| Operating Income | 4.31% | 21.78% | 21.57% | -17.05% | -33.79% |
| Income Before Tax | 25.76% | -136.11% | 8.35% | 159.39% | -915.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.76% | -136.11% | 8.35% | 159.39% | -915.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.91% | 16.27% | -27.35% | 110.42% | -37.37% |
| Net Income | 26.09% | -138.84% | 8.23% | 160.64% | -859.90% |
| EBIT | 4.31% | 21.78% | 21.57% | -17.05% | -33.79% |
| EBITDA | 2.57% | 16.75% | 16.84% | -27.99% | -45.43% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |